Where I see patients (1)
My reviews
Selected research
-
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
-
A combinatory vaccine with IMA950 plus varlilumab promotes effector memory T-cell differentiation in the peripheral blood of patients with low-grade gliomas.
Neuro-oncology
-
"De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade.
Acta neuropathologica
Clinical trials
Contact me
- Request appointment
- Refer a patient
- (415) 353-7500
4.9